Back to News
Market Impact: 0.2
Fresenius Medical Care Names Shervin Korangy CEO
Source: Nasdaq
Management & GovernanceHealthcare & Biotech
Fresenius Medical Care said Shervin J. Korangy will become CEO and Chair of the Management Board effective October 12, 2026, succeeding Helen Giza. The article provides no further details on the transition or its expected business impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- ‘I drive a Tesla’: After Elon Musk said he’d lose his job, Delta CEO Ed Bastian says there’s ‘no tit for tat’ as airline unveils earnings miss
- Trump created a committee to dig into the Fed's Lisa Cook. What is it and what comes next?
- ‘Indentured servants’: US green card move will hit thousands of IT workers
- Teva wins FDA approval for monthly schizophrenia injection Weltruza
- BofA downgrades Alignment Healthcare stock rating on star rating drop
- Humana Stock Jumps on Raised Medicare Advantage Ratings